This Massachusetts‑based neurology and sleep medicine practice offers consistent revenue growth, high margins, and minimal debt, making it an attractive acquisition opportunity.
Revenue is ~99% insurance collections, with a diversified payer mix: Medicare, BCBS, MassHealth, and other commercial plans. Incentive payments contribute marginally.
Referrals are highly concentrated, with 98% from primary care physicians and 40% from the practice’s own group. Despite no formal marketing, the lab maintains strong demand and reliable insurance authorizations.
Operations and Services
The practice performs ~336 in‑lab sleep studies annually, operating at ~90% utilization across four nights per week with two beds.
Core services include polysomnography, CPAP titration, home sleep apnea testing, EEG/AEEG, EMG/NCS, and neurology care for headaches and movement disorders. Primary care and infectious disease management are also offered.
Facilities and Equipment
The practice operates from 1,068 sq. ft. leased space in a 30,000 sq. ft. medical building, with two sleep beds and CleveMed diagnostic systems. Equipment is fully paid for.
Competition:
The practice competes with two large physician groups in the region but maintains an edge in successfully securing prior authorizations. Demand for sleep studies remains strong, supporting continued growth.
Potential Growth:
Expansion opportunities include scaling home sleep testing (HSAT), integrating CPAP/DME resupply, adding a nurse practitioner, and launching tele‑sleep services. Marketing initiatives and deeper engagement with the ACO network could significantly increase referrals. Facility expansion and equipment modernization provide additional upside.
